- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Heidelberg, Universität Heidelberg, Dissertation, 2024
- Schlagwort
-
Immuntherapie
Gliom
Krebs
Glioma
Immunotherapy
- Ereignis
-
Veröffentlichung
- (wo)
-
Heidelberg
- (wer)
-
Universitätsbibliothek Heidelberg
- (wann)
-
2024
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.11588/heidok.00035845
- URN
-
urn:nbn:de:bsz:16-heidok-358455
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chih, Yu-Chan
- Platten, Michael
- Universitätsbibliothek Heidelberg
Entstanden
- 2024
Ähnliche Objekte (12)
Chemotherapy and immunotherapy of malignat gliomas
Computational immunology : from MHC-peptide binding to immunotherapy
Immunotherapy with heat shock protein 96 to treat gliomas
PRG3 induces Ras-dependent oncogenic cooperation in gliomas
Combination immunotherapy overcomes resistance in MHC class I-deficient cancer
Facile repurposing of peptide–MHC-restricted antibodies for cancer immunotherapy
MHC-I genotype and tumor mutational burden predict response to immunotherapy
Peptide-dependent trafficking of MHC class I molecules
Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas
ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I
Cancer Immunotherapy Requires Interferon-dependent Senescence Induction
Towards designing improved cancer immunotherapy targets with a peptide-MHC-I presentation model, HLApollo
Chemotherapy and immunotherapy of malignat gliomas
Computational immunology : from MHC-peptide binding to immunotherapy
Immunotherapy with heat shock protein 96 to treat gliomas
PRG3 induces Ras-dependent oncogenic cooperation in gliomas
Combination immunotherapy overcomes resistance in MHC class I-deficient cancer
Facile repurposing of peptide–MHC-restricted antibodies for cancer immunotherapy
MHC-I genotype and tumor mutational burden predict response to immunotherapy
Peptide-dependent trafficking of MHC class I molecules
Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas
ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I
Cancer Immunotherapy Requires Interferon-dependent Senescence Induction
Towards designing improved cancer immunotherapy targets with a peptide-MHC-I presentation model, HLApollo
Chemotherapy and immunotherapy of malignat gliomas
Computational immunology : from MHC-peptide binding to immunotherapy
Immunotherapy with heat shock protein 96 to treat gliomas
PRG3 induces Ras-dependent oncogenic cooperation in gliomas
Combination immunotherapy overcomes resistance in MHC class I-deficient cancer
Facile repurposing of peptide–MHC-restricted antibodies for cancer immunotherapy
MHC-I genotype and tumor mutational burden predict response to immunotherapy
Peptide-dependent trafficking of MHC class I molecules
Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas
ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I
Cancer Immunotherapy Requires Interferon-dependent Senescence Induction